Lykis Ltd
Lykis Ltd offers simplified solutions for FMCG range of products by providing manufacturing support and end-to-end solutions for private labeling. [1]
- Market Cap ₹ 98.6 Cr.
- Current Price ₹ 50.9
- High / Low ₹ 58.0 / 22.9
- Stock P/E 9.00
- Book Value ₹ 8.08
- Dividend Yield 0.00 %
- ROCE 5.63 %
- ROE 22.6 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 22.0% CAGR over last 5 years
- Company's working capital requirements have reduced from 159 days to 122 days
Cons
- Stock is trading at 6.30 times its book value
- Company has a low return on equity of -15.2% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.19 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
22 | 129 | 168 | 107 | 107 | 148 | 147 | 84 | 63 | 329 | 402 | |
24 | 130 | 166 | 104 | 110 | 149 | 145 | 85 | 71 | 329 | 390 | |
Operating Profit | -2 | -1 | 2 | 2 | -3 | -1 | 2 | -1 | -8 | 0 | 12 |
OPM % | -9% | -1% | 1% | 2% | -3% | -1% | 2% | -1% | -12% | 0% | 3% |
1 | 2 | 1 | 1 | 3 | 3 | -1 | 2 | 1 | 6 | 4 | |
Interest | 1 | 1 | 2 | 2 | 3 | 5 | 2 | 3 | 2 | 3 | 4 |
Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 2 |
Profit before tax | -2 | -1 | 0 | 1 | -3 | -4 | -2 | -2 | -9 | 2 | 11 |
Tax % | -3% | -55% | 76% | 64% | -4% | 3% | -45% | 0% | 28% | -7% | |
Net Profit | -2 | -1 | 0 | 0 | -3 | -4 | -2 | -2 | -7 | 2 | 11 |
EPS in Rs | -0.62 | -1.02 | 0.06 | 0.18 | -1.78 | -1.85 | -1.25 | -0.98 | -3.47 | 1.25 | 5.66 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 25% |
3 Years: | 31% |
TTM: | 49% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 56% |
TTM: | 241% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 6% |
3 Years: | 41% |
1 Year: | 37% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -14% |
3 Years: | -15% |
Last Year: | 23% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
15 | 19 | 19 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |
Reserves | 4 | 5 | 5 | 8 | 3 | -3 | -2 | -4 | -10 | -8 | -4 |
3 | 45 | 62 | 52 | 86 | 113 | 43 | 49 | 51 | 113 | 146 | |
15 | 12 | 17 | 24 | 10 | 44 | 36 | 10 | 27 | 11 | 16 | |
Total Liabilities | 37 | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 178 |
12 | 12 | 11 | 13 | 13 | 14 | 13 | 15 | 3 | 4 | 6 | |
CWIP | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
Investments | 0 | 10 | 5 | 12 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
24 | 59 | 84 | 79 | 105 | 159 | 83 | 59 | 85 | 130 | 172 | |
Total Assets | 37 | 82 | 102 | 104 | 119 | 174 | 98 | 76 | 88 | 135 | 178 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
-11 | -29 | -22 | 15 | -33 | 2 | 36 | 9 | -22 | -64 | |
-0 | -11 | 4 | -8 | 9 | 0 | 2 | -0 | 9 | 10 | |
14 | 44 | 16 | -6 | 33 | 23 | -68 | -8 | 13 | 57 | |
Net Cash Flow | 3 | 5 | -2 | 2 | 10 | 25 | -30 | 1 | 0 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 122 | 60 | 96 | 75 | 107 | 74 | 49 | 40 | 114 | 67 |
Inventory Days | 64 | 9 | 8 | 20 | 19 | 23 | 14 | 4 | 80 | 18 |
Days Payable | 161 | 31 | 32 | 10 | 20 | 18 | 45 | 22 | 56 | 11 |
Cash Conversion Cycle | 25 | 38 | 72 | 85 | 105 | 79 | 18 | 22 | 138 | 73 |
Working Capital Days | 179 | 110 | 135 | 162 | 263 | 168 | 87 | 112 | 243 | 122 |
ROCE % | 1% | 2% | 4% | -0% | 1% | 3% | 1% | -12% | 6% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16h
- Financial Result For The Quarter And Nine Months Ended December 31, 2022. 1d
- Board Meeting Outcome for Intimation About Outcome Of The Board Meeting Held Today I.E. January 30, 2023 1d
- Board Meeting Intimation for Consideration And Approval Of Financial Results For The Quarter And Nine Months Ended December 31, 2022. 23 Jan
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Jan - Certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulation, 2018 for the quarter ended December 31, 2022.
Product Portfolio
The Co. offers a diverse range of consumer products in all the major segments such as Skin Care, Hair Care, Oral Care, Soap, Fragrances, Food & Beverage, and OTC. The company has more than 400 products in its name. [1]